Drugs
Hyperthermia, or heat therapy, has been shown to induce apoptosis in cancer cells, particularly in breast cancer cells. Recent research published in the Journal of Cellular Biochemistry has investigated the regulatory mechanisms of hyperthermia-induced apoptosis in MCF-7 breast cancer cells. The study found that hyperthermia exposure at 43°C increases
Drugs
Researchers have identified DNA licensing as a new androgen receptor (AR) mediated therapeutic target for prostate cancer. According to a study published in Endocrine-related Cancer, during the cell cycle, the androgen receptor plays a crucial role in regulating DNA replication and cell proliferation. In normal prostate cells, the androgen receptor
Drugs
Researchers at Tufts University's Medical Department conducted a clinical study to investigate the interactions of clarithromycin with zolpidem and trazodone. The study used a 5-way double crossover design with 10 healthy volunteers and administered the medications over a 32-hour period. The results showed that clarithromycin significantly impaired trazodone
Drugs
According to recent research from the National Cancer Institute, a phase II trial using sorafenib for metastatic castration-resistant prostate cancer has shown moderate activity as a second-line treatment. The trial, which involved 46 patients, found that sorafenib was associated with a median progression-free survival of 3.7 months and a
Drugs
Researchers in the United States have found that lysophosphatidic acid (LPA) plays a critical role in the initiation and progression of ovarian cancer. LPA is an autocrine growth signal that stimulates cell growth through distinct mechanisms in two ovarian cancer cell lines, SKOV-3 and Caov-3. The study, published in Pharmacology,
Drugs
Scientists in the United States have made a groundbreaking discovery in the fight against metastatic hormone-refractory prostate cancer (HRPC) using immunotherapy, a type of cancer treatment that harnesses the body's immune system to fight disease. The study, led by C.S. Higano and colleagues at the University of
Drugs
A recent study from researchers at the University of Leicester has revealed that anthocyanins, plant pigments found in fruits and berries, have the potential to delay cancer development in rodent models of colorectal carcinogenesis. The study highlights the anti-oncogenic mechanisms of anthocyanins and their aglycons, which include anti-proliferation, induction of
Drugs
Researchers at the University of Texas conducted a phase I trial of a novel combination of docetaxel, temozolomide, and cisplatin to treat metastatic melanoma. The study enrolled 23 patients with inoperable or recurrent metastatic melanoma, and the combination was found to be well-tolerated and showed promising results in treating the
Drugs
Researchers at the University of Thessaloniki in Greece have made significant progress in understanding the mechanisms of leukemia therapy, a critical advancement in the fight against blood cancers. According to a study published in Pharmacology and Therapeutics, human leukemias are considered clonal hematological malignancies initiated by chromosomal aberrations or epigenetic
Drugs
Scientists in the United States have made significant progress in elucidating the pleiotropic effects of HMG-CoA inhibitors, also known as statins, which include anti-inflammatory, antioxidative, and immunomodulatory properties. A recent study, published in the British Journal of Pharmacology, sheds light on the role of nitric oxide, peroxynitrite, and hem oxygenase-1
Drugs
Diabetes mellitus is a complex metabolic disorder that exhibits widespread endothelial and cardiac dysfunction, characterized by reduced nitric oxide production. Researchers in Heidelberg, Germany, have provided new insights into the potential benefits of phosphodiesterase-5 inhibitors in mitigating diabetic cardiovascular dysfunction. By up-regulating the nitric oxide-cGMP pathway in the vessel wall
Drugs
Scientists have discovered that the antimalarial drug artemisinin can induce resistance to doxorubicin in human colon cancer cells. This resistance is triggered by the activation of the hypoxia-inducible factor 1-alpha (HIF-1 alpha) and the overexpression of the P-glycoprotein (Pgp). Artemisinin and its structural homologue parthenolide were found to inhibit the
